Hsa_circ_0020095 modulates chemoresistance of CRC in a PDO model

BackgroundColorectal cancer (CRC) is the third most common malignant tumor type all over the world with high mortality. Chemoresistance of CRC leads to treatment failure and disease aggravation. We previously identified Hsa_circ_0020095 as a novel oncogene to promote progression and cisplatin-resist...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinyu Li, Tao Li, Yan Zhao, Junqi Shan, Yang Gao, Changchun Zhou, Yanlai Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1556611/full
Tags: Add Tag
No Tags, Be the first to tag this record!